ReviewCancers2022
Metastasis-Directed Radiation Therapy with Consolidative Intent for Oligometastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Stereotactic body radiotherapy for bone-only oligometastatic bladder Cancer: a multi-institutional experience.Clinical and translational radiation oncology · 2026Article
- Article
- Metastasis-Directed Surgery for Solitary Pulmonary Metastasis After Pembrolizumab in Urothelial Carcinoma: A Case Report.IJU case reports · 2026Article
- Consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology on the management of muscle-invasive and advanced urothelial carcinoma.Frontiers in oncology · 2025Review
- Biomarkers for predicting bladder cancer therapy response.Oncology research · 2025Review
- Stoma Acceptance Mediates Body Image Distress and Mental Health-Related Quality of Life: A Single-Center Study on Radical Cystectomy Patients with Ureterostomy.Journal of clinical medicine · 2024Article
- 2024 CUA-GUMOC Expert Report: Management of unresectable locally advanced and metastatic urothelial carcinoma.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2024Article
- Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study.Scientific reports · 2024Article
- Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience.Radiation oncology (London, England) · 2024Article
- Article
- Occult urothelial carcinoma with mediastinal metastasis: A case report.Oncology letters · 2024Article
- Identification of Molecular Mechanisms in Radiation Cystitis: Insights from RNA Sequencing.International journal of molecular sciences · 2024Article
- A Real-World Retrospective Analysis of the Management of Advanced Urothelial Carcinoma in Canada.Current oncology (Toronto, Ont.) · 2024Article
- Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts.Current oncology reports · 2023Review
- Defining Oligometastatic Bladder Cancer: A Systematic Review.European urology open science · 2023Review
- Clinical application and efficacy analysis of partial cystectomy combined with intravesical chemotherapy in muscle-invasive bladder cancer.BMC urology · 2023Article
- Article
- Optimal Systemic Treatment of Advanced Bladder Cancer Calls for a Multidisciplinary Approach.Cancers · 2023Article
- Radiotherapy Use in Muscle-Invasive Bladder Cancer: Review of the Guidelines and Impact of Increased Awareness in Patient Referral at a Tertiary Center in Belgium.Cancer management and research · 2023Article
- Metastasis-directed radiotherapy for oligometastatic urothelial carcinoma of the bladder and upper tract.Bladder cancer (Amsterdam, Netherlands)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The management of patients with oligometastatic urothelial carcinoma (UC) represents an evolving field in uro-oncology, and the role of metastasis-directed therapies, including metastasectomy and metastasis-directed radiation therapy (MDRT), is gaining increasing attention. Herein, we summarize available evidence about the role of MDRT with consolidative intent in oligometastatic UC patients. A systematic review was performed in December 2021. Six studies involving 158 patients were identified. Most patients (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.